StockStory.org on MSN
ResMed (RMD): Buy, sell, or hold post Q2 earnings?
ResMed currently trades at $218.94 per share and has shown little upside over the past six months, posting a small loss of ...
I think these three ASX shares have enough going for them to outperform over the next 12 months. The post 3 ASX 200 shares I ...
A deep-dive comparison of ResMed and Fisher & Paykel Healthcare shares: dividends, valuation, recent momentum, and which I ...
COWZ, QUAL, and SPHQ each aim to put you in higher-quality companies, but their portfolios barely recognize each other. Before you stack two of these funds for diversification, you need to see how ...
Air Voel, a Canadian online CPAP retailer, highlights the importance of mask fit, seal and comfort in positive airway ...
The Form 144 notice identifies Farrell as an officer and director and records the proposed sale through Fidelity Brokerage Services on the New York Stock Exchange. It also lists a cash-paid stock ...
ResMed stock is at EUR 199.20 pre-market on October 6, 2026, at 8:28 a.m. CEST, according to Lang & Schwarz. That is a plus 0 ...
How big is the respiratory care devices market, and what is driving its growth? The global respiratory care devices market is ...
Farrell exercised 4,991 ResMed common stock options at an exercise price of $146.34 per share on October 7, 2026. Share Sale: The identical 4,991 ...
NEW YORK, Oct. 6, 2026 /PRNewswire/ -- Cadara™, formerly National Care Systems, today announced a series of executive ...
Just 23 of the 200 companies on the Small Ordinaries index were trading higher in the year to October 1, and fund managers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results